Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 296
6
Diseases
17
Unique genes
0.192
Avg. similarity score
Bicuspid aortic valve
Most-connected disease (5 links)
Disease
Searched: Keratosis palmoplantaris striata
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Keratosis palmoplantaris striata
Bicuspid aortic valve
Congenital erythroderma with palmoplantar keratoderma, hypotrichosis, and hyper-ige
Diffuse palmoplantar keratoderma
Focal palmoplantar keratoderma with joint keratoses
aortic valve disease 3
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bicuspid aortic valve | 5 | 5 | 14 |
| Congenital erythroderma with palmoplantar keratoderma, hypotrichosis, and hyper-ige | 4 | 4 | 1 |
| Diffuse palmoplantar keratoderma | 4 | 4 | 2 |
| Focal palmoplantar keratoderma with joint keratoses | 4 | 4 | 1 |
| Keratosis palmoplantaris striata | 4 | 4 | 4 |
| aortic valve disease 3 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| DSG1 | 5 / 6 | Bicuspid aortic valve, Congenital erythroderma with palmoplantar keratoderma, hypotrichosis, and hyper-ige, Diffuse palmoplantar keratoderma, Focal palmoplantar keratoderma with joint keratoses and 1 more |
| DSP | 2 / 6 | Bicuspid aortic valve, Keratosis palmoplantaris striata |
| ROBO4 | 2 / 6 | aortic valve disease 3, Bicuspid aortic valve |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Apoptotic cleavage of cell adhesion proteins | Reactome | 2 / 11 | 128× | 1.03e-4 | 2.24e-3 ✓ sig. |
| Formation of ATP by chemiosmotic coupling | Reactome | 2 / 18 | 78.5× | 2.85e-4 | 5.04e-3 ✓ sig. |
| Cristae formation | Reactome | 2 / 18 | 78.5× | 2.85e-4 | 5.04e-3 ✓ sig. |
| Formation of the cornified envelope | Reactome | 3 / 130 | 16.3× | 7.54e-4 | 1.08e-2 ✓ sig. |
| Keratinization | Reactome | 3 / 152 | 13.9× | 1.19e-3 | 1.53e-2 ✓ sig. |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | Reactome | 1 / 1 | 706× | 1.42e-3 | 1.75e-2 ✓ sig. |
| Prion disease | KEGG | 3 / 275 | 7.7× | 6.37e-3 | 5.16e-2 |
| Defective LFNG causes SCDO3 | Reactome | 1 / 5 | 141× | 7.06e-3 | 5.50e-2 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | Reactome | 1 / 5 | 141× | 7.06e-3 | 5.50e-2 |
| Pre-NOTCH Processing in Golgi | Reactome | 1 / 6 | 118× | 8.46e-3 | 6.23e-2 |
| RUNX2 regulates bone development | Reactome | 1 / 7 | 101× | 9.87e-3 | 6.88e-2 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | Reactome | 1 / 7 | 101× | 9.87e-3 | 6.88e-2 |
| IRAK2 mediated activation of TAK1 complex | Reactome | 1 / 10 | 70.6× | 1.41e-2 | 8.52e-2 |
| Activated NOTCH1 Transmits Signal to the Nucleus | Reactome | 1 / 10 | 70.6× | 1.41e-2 | 8.52e-2 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | Reactome | 1 / 11 | 64.2× | 1.55e-2 | 9.04e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| aortic valve morphogenesis | GO:0003180 | 4 / 37 | 119× | 3.04e-8 | 4.39e-6 ✓ sig. |
| atrioventricular node development | GO:0003162 | 2 / 6 | 366× | 1.17e-5 | 5.91e-4 ✓ sig. |
| cardiac ventricle morphogenesis | GO:0003208 | 2 / 10 | 220× | 3.49e-5 | 1.38e-3 ✓ sig. |
| cardiac muscle tissue morphogenesis | GO:0055008 | 2 / 13 | 169× | 6.04e-5 | 2.08e-3 ✓ sig. |
| ventricular trabecula myocardium morphogenesis | GO:0003222 | 2 / 15 | 147× | 8.12e-5 | 2.60e-3 ✓ sig. |
| heart development | GO:0007507 | 4 / 273 | 16.1× | 9.13e-5 | 2.83e-3 ✓ sig. |
| cardiac septum morphogenesis | GO:0060411 | 2 / 16 | 137× | 9.28e-5 | 2.87e-3 ✓ sig. |
| pulmonary valve morphogenesis | GO:0003184 | 2 / 18 | 122× | 1.18e-4 | 3.43e-3 ✓ sig. |
| negative regulation of cardiac muscle hypertrophy | GO:0010614 | 2 / 18 | 122× | 1.18e-4 | 3.43e-3 ✓ sig. |
| negative regulation of myotube differentiation | GO:0010832 | 2 / 18 | 122× | 1.18e-4 | 3.43e-3 ✓ sig. |
| peptide cross-linking | GO:0018149 | 2 / 19 | 116× | 1.32e-4 | 3.74e-3 ✓ sig. |
| proton motive force-driven ATP synthesis | GO:0015986 | 2 / 23 | 95.6× | 1.95e-4 | 4.96e-3 ✓ sig. |
| cardiac muscle tissue development | GO:0048738 | 2 / 24 | 91.6× | 2.12e-4 | 5.27e-3 ✓ sig. |
| cell differentiation | GO:0030154 | 6 / 1,051 | 6.3× | 2.26e-4 | 5.48e-3 ✓ sig. |
| cardiac muscle cell development | GO:0055013 | 2 / 25 | 87.9× | 2.31e-4 | 5.57e-3 ✓ sig. |